Cardiovascular Revascularization Medicine
Volume 7, Issue 4 , Pages 212-216, October 2006

The effect of calcium dobesilate on venous function following saphenectomy in coronary artery bypass grafting

  • Kerim Cagli

      Affiliations

    • Department of Cardiovascular Surgery, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Kırkkonaklar Mah. Semsettin Gunaltay Cad. 17.Sok. No:1/13 06610 Cankaya, Ankara, Turkey. Tel.: +90 312 306 12 28; fax: +90 312 312 41 20.
  • ,
  • Kanat Ozisik

      Affiliations

    • Department of Cardiovascular Surgery, Numune Education and Research Hospital, Ankara, Turkey
  • ,
  • Mustafa Emir

      Affiliations

    • Department of Cardiovascular Surgery, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey
  • ,
  • Okan Yurdakok

      Affiliations

    • Department of Cardiovascular Surgery, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey
  • ,
  • Sami Gurkahraman

      Affiliations

    • Department of Cardiovascular Surgery, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey
  • ,
  • Vedat Bakuy

      Affiliations

    • Department of Cardiovascular Surgery, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey
  • ,
  • Muharrem Tola

      Affiliations

    • Department of Radiology, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey
  • ,
  • Mustafa Pac

      Affiliations

    • Department of Cardiovascular Surgery, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey
  • ,
  • Adnan Cobanoglu

      Affiliations

    • Department of Cardiovascular Surgery, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey

Received 22 June 2006; accepted 28 June 2006.

Abstract 

Background

The aim of this study was to determine whether prophylactic use of calcium dobesilate (CD) can improve venous function after saphenous vein harvest in coronary artery bypass graft (CABG).

Materials and Methods

A total of 100 patients who underwent elective CABG were divided into four equal groups. In Group A, the greater saphenous vein (GSV) was harvested below the knee and, in Group B, through the knee till the groin. These patients remained untreated. Group C received CD in a dosage of 1500 mg po daily after the GSV was harvested below the knee. Group D received same dosage of CD after the GSV was harvested through the knee till the groin. Venous function of ipsilateral leg was evaluated clinically and by Doppler ultrasonography in the postoperative first week and second month.

Results

Clinical findings of venous insufficiency were observed with a similar rate between groups at both early and late periods. In Groups A and B, after 2 months, flow velocities decreased and reflux periods increased significantly. In groups C and D, treatment with CD for 2 months after saphenectomy resulted in a significant increase in flow velocities and a significant decrease in reflux periods. Patients in Groups B and D have significantly more impaired venous functions.

Conclusion

Saphenectomy results in ipsilateral leg venous dysfunction, which seems to be unrelated to leg swelling and to be more prominent in patients with high-level saphenectomy. In addition, to be careful about the restriction of the saphenectomy procedure into the most appropriate level, prophylactic use of CD can prevent this deterioration when it was added to varice socks.

Keywords: Calcium dobesilate, Saphenectomy, Coronary artery bypass graft

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1553-8389(06)00182-5

doi:10.1016/j.carrev.2006.06.003

Cardiovascular Revascularization Medicine
Volume 7, Issue 4 , Pages 212-216, October 2006